Interferon inducibility and sensitivity of human teratocarcinoma-derived cell lines.
Three cell lines tera I, tera II, and PA1, derived from human teratocarcinomas were tested for their capacity to produce interferon (IFN) and for their sensitivity to both human IFN-alpha and IFN-beta. When treated with Newcastle disease virus or Sendai virus, or a synthetic polyribonucleotide, poly(rI):poly(rC), tera I cells produced no IFN and the 2',5'-oligoadenylate (2-5A) synthetase enzymatic pathway was not activated, although there was an increase in protein kinase. In contrast, tera II and PA1 cells produced IFN and both enzymatic activities were detected. IFN treatment has no effect on the growth of any of the cell lines. Tera I and PA1 cells did not develop resistance to challenge with vesicular stomatitis virus or encephalomyocarditis virus, but the growth of a type-C baboon retrovirus was inhibited. Tera II cells were protected against all three viruses. It appears that human teratocarcinoma cell lines can thus differ greatly in their ability to produce IFN and to respond to it.
D015088:2',5'-Oligoadenylate Synthetase / Q000096:biosynthesis; D002460:Cell Line; D004351:Drug Resistance; D004686:Encephalomyocarditis virus / Q000254:growth & development; D006801:Humans; D007372:Interferons / Q000096:biosynthesis* / Q000494:pharmacology; D009522:Newcastle disease virus / Q000276:immunology; D010222:Parainfluenza Virus 1, Human / Q000276:immunology; D011070:Poly I-C / Q000494:pharmacology; D011494:Protein Kinases / Q000096:biosynthesis; D012190:Retroviridae / Q000254:growth & development; D013724:Teratoma / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology; D014721:Vesicular stomatitis Indiana virus / Q000254:growth & development; D014779:Virus Replication / Q000187:drug effects
D007372:Interferons; D011494:Protein Kinases; D015088:2',5'-Oligoadenylate Synthetase; D011070:Poly I-C